The acquisition will help Digital Pharmacist accelerate its product development schedule, and expand its reach to over 6,000 pharmacies nationwide.
It currently operates in over 40 cities in China, and has over 50,000 pharmacy companies signed onto the platform; it will use the funds to keep growing.
Globally, revenue loss has increased from $564 billion in 2012 to $637 billion in 2015, with US-based revenue losses increasing from $188 billion in 2012 to $250 billion in 2015.
Takeda Pharmaceutical Company will rely on Koneksa Health's technology data platform to integrate biosensor and wearable technology in several of its early stage clinical studies.
The new Medisafe iConnect devices, including iCap and iSort, are Bluetooth connected and can work in tandem with Medisafe's software.
The solution is easy to use, and can adapt to any medication routine; also, it works whether a person manages their own or a loved one's pill regimen.
As part of the deal, Gloria will also get an 18-month period of exclusive negotiation with Proteus to establish a joint venture company in China.
The deployment has started with more than a dozen facilities across D-H's telehealth service area in New England with other markets coming in the future.
The sensor-laden device with a novel electronic dose counter is currently available for licensing and is expected to enter clinical studies later this year.
Located north of Toronto in Markham, LEO Innovation Lab will develop non-pharmaceutical solutions to treat psoriasis, which affects around 125 million people.